Children were the leading growth demographic for the pharmaceutical industry in 2009, with the increase of prescription drug use among youngsters nearly four times higher than in the overall population, according to a report by Medco Health Solutions Inc.
More than one in four insured children in the United States and nearly 30 percent of adolescents aged 10 to 19 took at least one prescription medicine to treat a chronic condition in 2009, according to an analysis of pediatric medication use conducted as part of Medco's drug trend study issued on Wednesday.
Medco is forecasting overall pharmaceutical spending to rise up to 18 percent through 2012, driven by diabetes, cancer and rheumatology treatments. Spending is expected to rise 3 percent to 5 percent this year, and 4 percent to 6 percent the next two years.
FOR SUBSCRIBERSA harrowing ordeal aboard an Israel-bound plane
FOR SUBSCRIBERSThe debate over AI’s future rages on both coasts
Overall increases will be somewhat held down by some $46 billion in branded drug sales that will succumb to competition from cheap generic versions by the end of 2012.
FOR SUBSCRIBERSA harrowing ordeal aboard an Israel-bound plane
FOR SUBSCRIBERSThe debate over AI’s future rages on both coasts
But the increases seen in prescription drug use by children for chronic conditions could fuel significantly higher U.S. health care costs as those young patients enter adulthood, Medco said.
Medco and other pharmacy benefit managers, or PBMs, administer prescription drug benefits for employers and health plans and also run large mail-order pharmacies.














